110
Participants
Start Date
November 1, 2020
Primary Completion Date
November 30, 2022
Study Completion Date
June 30, 2023
Xemio mobile application
"The study consists in a mHealth intervention provided through the Xemio mobile application for breast cancer survivors. This application is installed in the personal smartphones of the participants after they are randomized in the mHealth intervention group. The Xemio app components are symptom tracking, up-to-date calendar of events organized by patient's organizations, virtual talks with experts, articles regarding new information of the disease, physical activity tracking, and evidence-based information regarding symptoms, non-pharmacological treatments for side effects, and information about common drugs to treat breast cancer. The participants can freely use the Xemio mobile application for a total of 12 months.~The control group does not have access to the Xemio application for the duration of the study but they are offered access to it at the completion of the intervention. The participants of both arms continued to receive the usual care from their oncology teams."
Hospital Clínic, Barcelona
Fundacion iSYS, internet, salud y sociedad
UNKNOWN
Fundacion Clinic per a la Recerca Biomédica
OTHER